- Filed
- Sep 13, 2018 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2019 · Sep 1, 2018 | 16.85M sh |
| Shares Diluted | Q1 2019 · Jul 31, 2018 | 17.18M sh |
| Shares Diluted | Q1 2019 · Jul 31, 2017 | 17.78M sh |
| Capex | Q1 2019 · Jul 31, 2018 | $67.12K |
| Capex restated | Q1 2019 · Jul 31, 2017 | $225.98K |
| Long Term Debt | Q1 2019 · Jul 31, 2018 | $6.82M |
| Long Term Debt | Q1 2019 · Apr 30, 2018 | $7.9M |
| Cash And Equivalents | Q1 2019 · Jul 31, 2018 | $8.42M |
| Cash And Equivalents | Q1 2019 · Apr 30, 2018 | $9.51M |
| Stockholders Equity | Q1 2019 · Jul 31, 2018 | $34.18M |
| Stockholders Equity | Q1 2019 · Apr 30, 2018 | $34.25M |
| Current Liabilities | Q1 2019 · Jul 31, 2018 | $6.03M |
| Current Liabilities | Q1 2019 · Apr 30, 2018 | $6.34M |
| Total Liabilities | Q1 2019 · Jul 31, 2018 | $13.47M |
| Total Liabilities | Q1 2019 · Apr 30, 2018 | $14.87M |
| Current Assets | Q1 2019 · Jul 31, 2018 | $26.39M |
| Current Assets | Q1 2019 · Apr 30, 2018 | $14.23M |
| Total Assets | Q1 2019 · Jul 31, 2018 | $47.65M |
| Total Assets | Q1 2019 · Apr 30, 2018 | $49.12M |
| Eps Diluted | Q1 2019 · Jul 31, 2018 | $0.00 |
| Eps Diluted | Q1 2019 · Jul 31, 2017 | $0.01 |
| Sga Expense | Q1 2019 · Jul 31, 2018 | $4.47M |
| Sga Expense restated | Q1 2019 · Jul 31, 2017 | $4.36M |
| Net Income | Q1 2019 · Jul 31, 2018 | −$51.84K |
| Net Income | Q1 2019 · Jul 31, 2017 | $124K |
| Operating Income | Q1 2019 · Jul 31, 2018 | $217.03K |
| Operating Income restated | Q1 2019 · Jul 31, 2017 | $260.95K |
| Revenue | Q1 2019 · Jul 31, 2018 | $14.88M |
| Revenue restated | Q1 2019 · Jul 31, 2017 | $15M |
| Stock Repurchased | Q1 2019 · Jul 31, 2016 | $2M |